semaglutide pediatric Wegovy® for Adolescents with Obesity At Vitrah Clinic, we follow

A conversion chart is a vital tool used in medicine to ensure that patients receive equivalent therapeutic effects when switching from one medication to another

Ozempic led to an average loss of up to 4.7 kg (about 10 lbs) over 30 weeks, based on clinical trial comparisons

Semaglutide enhances glucose-dependent insulin secretion from pancreatic beta cells, meaning insulin release occurs primarily when blood glucose levels are elevated

semaglutide was then approved in 2021 under the brand name Wegovy for weight loss

By reducing hunger, lowering your appetite and increasing feelings of fullness, it will reduce your calorie intake and allow you to lose weight, 1-2 pounds a week